Concepedia

Angela Berry

AB

10

Publications

372

Citations

10

H-Index

2006

Active since

Affiliations

Boehringer Ingelheim (United States)(Current)

Evotec (Germany)

Boehringer Ingelheim (Germany)

Evotec (United Kingdom)

Evotec (United States)

Angela Berry is an author at Boehringer Ingelheim (United States) specializing in drug discovery, pharmacology, and medicine.

Top concepts

Publications per year

2006–2019

10

Publications

10

In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease

Brian L. Lin, Damian Matera, Julia F. Doerner et al. · Proceedings of the National Academy of Sciences · 2019 · 143 citations · Full text

Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β:  Part I:  Hit-to-Lead Strategies

Tina M. Morwick, Angela Berry, Janice R. Brickwood et al. · Journal of Medicinal Chemistry · 2006 · 67 citations · Full text

Identification of Highly Efficacious Glucocorticoid Receptor Agonists with a Potential for Reduced Clinical Bone Side Effects

Christian Harcken, Doris Riether, Daniel Kuzmich et al. · Journal of Medicinal Chemistry · 2014 · 31 citations · Full text

, , +17

Discovery and Optimization of p38 Inhibitors via Computer-Assisted Drug Design

Daniel R. Goldberg, Ming‐Hong Hao, Kevin Qian et al. · Journal of Medicinal Chemistry · 2007 · 24 citations · Full text

1,4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability

Doris Riether, Lifen Wu, Pier F. Cirillo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 21 citations · Full text

, , +11

Rows per page

1–5 of 10